InternationalUSRemember you can easily switch between MIP US and MIP International at any time

Canada IP Focus 2018

  • How the USMCA will affect Canadian IP

    The USMCA includes provisions for Canadian IP that extend protection for biologics and copyright, exporting what some observers see as the worst of US IP law to its northern neighbour. Ellie Mertens reports

  • The first steps taken at the Canadian pharmaceutical patent dance

    J Bradley White and Nathaniel Lipkus of Osler analyse the changes introduced by the amendments to the PMNOC Regulations, examining the rules around the 24-month timeline for actions, appropriate parties in a proceeding, NOAs, early patent dismissals, confidentiality and the 24-month stay

  • Top five reasons to consider patent litigation in Canada

    Steve Garland and Jean-Sébastien Dupont of Smart & Biggar consider five reasons why carrying out patent litigation in Canada is preferable to US proceedings, including no opportunity for forum shopping, no jury trials and no inter partes reviews


More from the Managing IP blog


null null null

null null null

null

November / December 2018

The 50 most influential people in IP

Managing IP reveals our pick of the people driving intellectual property law, policy and business this year. Read the full list here



Most read articles

Supplements